NYSE: BDX
Becton, Dickinson and Company
Healthcare · Medical - Instruments & Supplies
After hours: $161.25(+1.47%) · as of 6:23 PM ET
Market Cap
$57.58B
52w High
$187.35
52w Low
$127.59
P/E
39.19
Volume
980.15K
Outstanding Shares
362.30M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 10.5% over the last year. Revenue grew 2.39% over the trailing twelve months. Operating margin moved from 10.65% to 10.61%. Free cash flow grew 21.31% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 10.61%. A decisive move in revenue — currently up 2.39% — would be the clearest signal to resolve the ambiguity.
Company profile
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology.
Valuation
Stock splits
Every 125 shares became 159
Every 40 shares became 41
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
16
Buy
17
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 6, 2026
Q3 FY26 · EPS est $3.14 · Revenue est $4.89B
View
Dividends
$3.74/shareQuarterlyDividend Aristocrat · 42yrAt RiskBDX pays a dividend with a 2.36% dividend yield, 42 consecutive years of growth, growing at 8.27% annually, covered 2.2× by free cash flow.
Dividend Yield
2.36%
Annual Div / Share
$3.74
5yr CAGR
+8.27%
Doubles every ~8.7yr
Payout Ratio
104.13%
At Risk
Dividend Growth Rate
3yr CAGR
+9.76%
5yr CAGR
+8.27%
10yr CAGR
+6.58%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$2/mo
In 5 yrs
$3/mo
In 10 yrs
$4/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$24/yr $2/mo | $35/yr+49% $3/mo | $52/yr+121% $4/mo |
Yield-on-cost grows from 2.36% → 5.21% over 10yr
Analysis
Dividend Strengths
Dividend Aristocrat
BDX has raised its dividend for 42 consecutive years — qualifying as a Dividend Aristocrat, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 2.2× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 8.27% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
High payout ratio
With 104.13% of earnings paid as dividends, there is limited retained earnings for reinvestment — and a dividend cut becomes more likely if earnings decline.